Prion propagation, toxicity and degradation

Nature Neuroscience

Volumn 15, Issue 7, 2012, Pages 936-939

  Aguzzi, Adriano ^a   Falsig, Jeppe ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD TRANSFUSION; BOVINE SPONGIFORM ENCEPHALOPATHY; HUMAN; NONHUMAN; PRION; PRION DISEASE; PRIORITY JOURNAL; REVIEW; VIRUS CELL INTERACTION; VIRUS NEUTRALIZATION; VIRUS PATHOGENESIS; VIRUS TRANSMISSION;

AMINO ACID SEQUENCE; ANIMALS; HUMANS; MOLECULAR SEQUENCE DATA; PRION DISEASES; PRIONS; PROTEOLYSIS;

EID: 84862889276     PISSN: 10976256     EISSN: 15461726     Source Type: Journal    
DOI: 10.1038/nn.3120     Document Type: Review

References (50)

1. Büeler, H. et al. Mice devoid of PrP are resistant to scrapie. Cell 73, 1339-1347 (1993). (Pubitemid 23201147)
2. Prusiner, S.B. Novel proteinaceous infectious particles cause scrapie. Science 216, 136-144 (1982). (Pubitemid 12089840)
3. Knowles, T.P. et al. An analytical solution to the kinetics of breakable filament assembly. Science 326, 1533-1537 (2009).
4. Saborio, G.P., Permanne, B. & Soto, C. Sensitive detection of pathological prion protein by cyclic amplification of protein misfolding. Nature 411, 810-813 (2001). (Pubitemid 32588105)
5. Castilla, J., Saa, P., Hetz, C. & Soto, C. In vitro generation of infectious scrapie prions. Cell 121, 195-206 (2005). (Pubitemid 40546388)
6. Deleault, N.R., Harris, B.T., Rees, J.R. & Supattapone, S. Formation of native prions from minimal components in vitro. Proc. Natl. Acad. Sci. USA 104, 9741-9746 (2007). (Pubitemid 47175337)
7. Wang, F., Wang, X., Yuan, C.G. & Ma, J. Generating a prion with bacterially expressed recombinant prion protein. Science 327, 1132-1135 (2010).
8. Lesné, S. et al. A specific amyloid-beta protein assembly in the brain impairs memory. Nature 440, 352-357 (2006).
9. Shankar, G.M. et al. Amyloid-beta protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory. Nat. Med. 14, 837-842 (2008).
10. Laurén, J., Gimbel, D.A., Nygaard, H.B., Gilbert, J.W. & Strittmatter, S.M. Cellular prion protein mediates impairment of synaptic plasticity by amyloid-beta oligomers. Nature 457, 1128-1132 (2009).
11. Riek, R., Hornemann, S., Wider, G., Glockshuber, R. & Wüthrich, K. NMR characterization of the full-length recombinant murine prion protein, mPrP(23-231). FEBS Lett 413, 282-288 (1997). (Pubitemid 27353285)
12. Balducci, C. et al. Synthetic amyloid-beta oligomers impair long-term memory independently of cellular prion protein. Proc. Natl. Acad. Sci. USA 107, 2295-2300 (2010).
13. Cissé, M. et al. Ablation of cellular prion protein does not ameliorate abnormal neural network activity or cognitive dysfunction in the J20 line of human amyloid precursor protein transgenic mice. J. Neurosci. 31, 10427-10431 (2011).
14. Calella, A.M. et al. Prion protein and Abeta-related synaptic toxicity impairment. EMBO Mol. Med. 2, 306-314 (2010).
15. Gimbel, D.A. et al. Memory impairment in transgenic Alzheimer mice requires cellular prion protein. J. Neurosci. 30, 6367-6374 (2010).
16. Freir, D.B. et al. Interaction between prion protein and toxic amyloid β assemblies can be therapeutically targeted at multiple sites. Nat. Commun. 2, 336 (2011).
17. Barry, A.E. et al. Alzheimer's disease brain-derived amyloid-β- mediated inhibition of LTP in vivo is prevented by immunotargeting cellular prion protein. J. Neurosci. 31, 7259-7263 (2011).
18. Benilova, I., Karran, E. & De Strooper, B. The toxic Abeta oligomer and Alzheimer's disease: an emperor in need of clothes. Nat. Neurosci. 15, 349-357 (2012).
19. Brandner, S. et al. Normal host prion protein necessary for scrapie-induced neurotoxicity. Nature 379, 339-343 (1996). (Pubitemid 26033075)
20. Mallucci, G. et al. Depleting neuronal PrP in prion infection prevents disease and reverses spongiosis. Science 302, 871-874 (2003). (Pubitemid 37339628)
21. Chesebro, B. et al. Anchorless prion protein results in infectious amyloid disease without clinical scrapie. Science 308, 1435-1439 (2005). (Pubitemid 40791292)
22. Solforosi, L. et al. Cross-linking cellular prion protein triggers neuronal apoptosis in vivo. Science 303, 1514-1516 (2004). (Pubitemid 38314420)
23. Shmerling, D. et al. Expression of amino-terminally truncated PrP in the mouse leading to ataxia and specific cerebellar lesions. Cell 93, 203-214 (1998). (Pubitemid 28180854)
24. Sandberg, M.K., Al-Doujaily, H., Sharps, B., Clarke, A.R. & Collinge, J. Prion propagation and toxicity in vivo occur in two distinct mechanistic phases. Nature 470, 540-542 (2011).
25. Büeler, H. et al. High prion and PrPSc levels but delayed onset of disease in scrapie-inoculated mice heterozygous for a disrupted PrP gene. Mol. Med. 1, 19-30 (1994).
26. Stöhr, J. et al. Spontaneous generation of anchorless prions in transgenic mice. Proc. Natl. Acad. Sci. USA 108, 21223-21228 (2011).
27. Aguzzi, A. & Calella, A.M. Prions: protein aggregation and infectious diseases. Physiol. Rev. 89, 1105-1152 (2009).
28. Khosravani, H. et al. Prion protein attenuates excitotoxicity by inhibiting NMDA receptors. J. Cell Biol. 181, 551-565 (2008).
29. You, H. et al. Abeta neurotoxicity depends on interactions between copper ions, prion protein and N-methyl-d-aspartate receptors. Proc. Natl. Acad. Sci. USA 109, 1737-1742 (2012).
30. Ma, J. & Lindquist, S. Wild-type PrP and a mutant associated with prion disease are subject to retrograde transport and proteasome degradation. Proc. Natl. Acad. Sci. USA 98, 14955-14960 (2001). (Pubitemid 34013951)
31. Hegde, R.S. et al. A transmembrane form of the prion protein in neurodegenerative disease. Science 279, 827-834 (1998). (Pubitemid 28106269)
32. Chakrabarti, O. & Hegde, R.S. Functional depletion of mahogunin by cytosolically exposed prion protein contributes to neurodegeneration. Cell 137, 1136-1147 (2009).
33. Aguzzi, A. & Steele, A.D. Prion topology and toxicity. Cell 137, 994-996 (2009).
34. Behrens, A. & Aguzzi, A. Small is not beautiful: antagonizing functions for the prion protein PrP(C) and its homologue Dpl. Trends Neurosci. 25, 150-154 (2002). (Pubitemid 34164340)
35. Solomon, I.H., Huettner, J.E. & Harris, D.A. Neurotoxic mutants of the prion protein induce spontaneous ionic currents in cultured cells. J. Biol. Chem. 285, 26719-26726 (2010).
36. Solomon, I.H. et al. An N-terminal polybasic domain and cell surface localization are required for mutant prion protein toxicity. J. Biol. Chem. 286, 14724-14736 (2011).
37. Solomon, I.H., Biasini, E. & Harris, D.A. Ion channels induced by the prion protein: mediators of neurotoxicity. Prion 6, 40-45 (2012).
38. Bellinger-Kawahara, C., Cleaver, J.E., Diener, T.O. & Prusiner, S.B. Purified scrapie prions resist inactivation by UV irradiation. J. Virol. 61, 159-166 (1987). (Pubitemid 17212457)
39. Brown, P. & Gajdusek, D.C. Survival of scrapie virus after 3 years' interment. Lancet 337, 269-270 (1991).
40. Peretz, D. et al. Antibodies inhibit prion propagation and clear cell cultures of prion infectivity. Nature 412, 739-743 (2001). (Pubitemid 32771997)
41. Safar, J.G. et al. Prion clearance in bigenic mice. J. Gen. Virol. 86, 2913-2923 (2005). (Pubitemid 41410483)
42. Chernoff, Y.O., Lindquist, S.L., Ono, B., Inge Vechtomov, S.G. & Liebman, S.W. Role of the chaperone protein Hsp104 in propagation of the yeast prion-like factor. Science 268, 880-884 (1995).
43. Luhr, K.M. et al. Scrapie protein degradation by cysteine proteases in CD11c(+) dendritic cells and GT1-1 neuronal cells. J. Virol. 78, 4776-4782 (2004). (Pubitemid 38501098)
44. Beringue, V. et al. Role of spleen macrophages in the clearance of scrapie agent early in pathogenesis. J. Pathol. 190, 495-502 (2000). (Pubitemid 30163592)
45. Falsig, J. et al. A versatile prion replication assay in organotypic brain slices. Nat. Neurosci. 11, 109-117 (2008).
46. Flores-Langarica, A., Sebti, Y., Mitchell, D.A., Sim, R.B. & MacPherson, G.G. Scrapie pathogenesis: the role of complement C1q in scrapie agent uptake by conventional dendritic cells. J. Immunol. 182, 1305-1313 (2009).
47. Baker, C.A., Martin, D. & Manuelidis, L. Microglia from Creutzfeldt-Jakob disease-infected brains are infectious and show specific mRNA activation profiles. J. Virol. 76, 10905-10913 (2002). (Pubitemid 35176207)
48. Kranich, J. et al. Engulfment of cerebral apoptotic bodies controls the course of prion disease in a mouse strain-dependent manner. J. Exp. Med. 207, 2271-2281 (2010).
49. Ghaemmaghami, S. et al. Cell division modulates prion accumulation in cultured cells. Proc. Natl. Acad. Sci. USA 104, 17971-17976 (2007). (Pubitemid 350210805)
50. Mahal, S.P. et al. Prion strain discrimination in cell culture: the cell panel assay. Proc. Natl. Acad. Sci. USA 104, 20908-20913 (2007).